GlassScriptPhysician profile
Arash Olyie Naghavi
NPI 1396002788
$2,114.15
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2023: $273 · 2024: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058 · Travel and Lodging: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.96 |
| Travel and Lodging | $906.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $1,199.41 | 2024 | Icotec Blackarmor Spine System, Vader Pedicle System |
| Springworks Therapeutics, INC. | $346.73 | 2024 | Ogsiveo |
| Genentech USA, INC. | $149.99 | 2019 | |
| Servier Pharmaceuticals LLC | $125.00 | 2023 | |
| Deciphera Pharmaceuticals INC. | $124.95 | 2024 | Qinlock |
| Siemens Medical Solutions USA, INC. | $92.53 | 2023 | Bravos Afterloader System |
| Aadi Bioscience, INC. | $55.45 | 2023 | Fyarro |
| Becton, Dickinson and Company | $20.09 | 2024 | Bard Urinary Drainage Bag |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Naghavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.